Reconstructed adenoviruses found effective in cancer therapy

The use of adenoviruses in tumor therapy has been limited as they are efficiently neutralized by the immune system and very rapidly eliminated by the liver. Researchers led by Andreas Plueckthun, a professor at the Department of Biochemistry at the University of Zurich, have now succeeded in rebuilding the viruses so that they effectively recognize and infect tumor cells. "For this purpose, we have created molecules which act as an adapter between the virus and the tumor cell," explains Markus Schmid, first author of the study.

The adapters, which cling very tightly to the coat of the virus, can -- depending on their version -- bind to different surface molecules on the tumor cell. The scientists tested adapters for several receptors such as HER2 and EGFR, which are present in various types of cancer cells. Only viruses which were equipped with these adapters were able to infect the tumor cells.

New protein shield masks and protects against the immune system

In a next step, the researchers hid the virus under a novel protein coat, which serves as camouflage for the virus and which protects it from the immune system. As a basis for this shield, the researchers used an existing antibody that they redesigned. In an interdisciplinary collaboration between the different research teams, the exact architecture of the complete protective coat was described almost down to the level of atoms.

The shield does not only protect the redesigned virus from the immune cells but also prevents the virus from being eliminated by the liver, which normally quickly removes unmodified adenoviruses from the bloodstream, often making therapeutic applications impossible. The virus, redesigned using sophisticated protein engineering techniques, works: With its shield and its adapter, these viral gene shuttles efficiently infected tumor cells in laboratory animals.

Valuable tool for gene therapy of aggressive tumors

Using these stealth gene shuttles, the UZH scientists want to develop novel therapies for different types of cancer. The numerous advantages of adenoviruses will likely help to tackle one of the greatest problems of cancer medicine: The development of resistance against drugs. Biochemist Andreas Plueckthun is optimistic: "With this gene shuttle, we have opened up many avenues to treat aggressive cancers in the future, since we can make the body itself produce a whole cocktail of therapeutics directly in the tumor."